This inventor holds 1 USPTO granted patent. Top assignees: Lg Life Sciences, Limited, Yamanouchi Pharmaceutical Company Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: In-Ae Ahn: Innovator in Melanocortin Receptor Agonists
Introduction
In-Ae Ahn is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmacology, particularly through his work on melanocortin receptor agonists. His innovative approach has led to the development of a compound that holds promise for various therapeutic applications.
Latest Patents
In-Ae Ahn holds one patent related to melanocortin receptor agonists. The patent describes a compound of formula 1, along with its pharmaceutically acceptable salts, hydrates, solvates, or isomers. This compound is effective as an agonist of the melanocortin receptor and is part of an agonistic composition that includes the same as an active ingredient.
Career Highlights
Throughout his career, In-Ae Ahn has worked with prominent companies in the pharmaceutical industry. He has been associated with LG Life Sciences and Yamanouchi Pharmaceutical Company Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
In his professional journey, In-Ae Ahn has collaborated with notable colleagues, including Koo Lee and Heui-Sul Park. Their combined efforts have furthered research and development in the field of melanocortin receptor agonists.
Conclusion
In-Ae Ahn's work in developing melanocortin receptor agonists showcases his innovative spirit and dedication to advancing pharmacological science. His contributions are significant in the ongoing quest for effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile